Related Experiment Video
Updated: Jul 2, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Simultaneous vaccination with Prevenar and multicomponent vaccines for children: interference or no interference?
Hein J Boot1, C Maarten A Schipper
1Laboratory for Infectious Diseases and Perinatal Screening, Centre for Infectious Diseases Control Netherlands, National Institute for Public Health and the Environment, RIVM, Bilthoven, The Netherlands. Hein.Boot@RIVM.NL
Insights
Simultaneous vaccinations with Infanrix hexa and Prevanar may lead to suboptimal immune responses. Further assessment of vaccine interference is crucial before widespread use in national immunization programs.
Area of Science:
- Pediatric Vaccinology
- Immunology
- Public Health
Background:
- Simultaneous administration of multiple vaccines is common in national immunization programs.
- Potential for suboptimal immune responses exists when combining different vaccines, impacting vaccine efficacy.
Purpose of the Study:
- To evaluate the immune response to simultaneous vaccination with Infanrix hexa and Prevanar.
- To assess potential interferences between these vaccines and their impact on seroconversion rates.
Main Methods:
- A random-effect meta-analysis was conducted using data from two published studies.
- The analysis focused on the Hepatitis B virus (HBV) seroconversion rate following combined vaccination.
Main Results:
- The 95% confidence interval for the HBV seroconversion rate included the minimum threshold required for universal immunization programs.
- This suggests a potential for reduced efficacy when these vaccines are given together.
Conclusions:
- There is a need for better assessment of immune response interference when administering simultaneous vaccinations.
- Vaccine registration processes should incorporate evaluations of potential interactions to ensure public health program effectiveness.
Abstract:
Multicomponent vaccines against as many as six infectious diseases are often given simultaneously with monovalent or multivalent vaccines against meningococcus and pneumococcus. Detailed analysis of simultaneous vaccinations, which can lead to suboptimal induced immune responses, should precede their combined use in national immunization programmes. By combining the results of the only two published studies evaluating simultaneous vaccinations with Infanrix hexa and Prevanar in a random-effect meta-analysis, we show that the one-sided 95% confidence interval of the HBV seroconversion rate includes the 95% limit that should be reached in universal programs. We advocate better assessment of potential interferences in immune responses after simultaneous vaccinations. Registration of new vaccines should include this assessment.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Smallpox
Drug Dosing: Infants and Children
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Cross-reactivity